Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Marine Derived Drugs Market by Type (Mollusk, Sponge, Tunicate, Fish, Others), By Application (Antitumor Drugs, Anti-Cardiovascul) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Marine Derived Drugs Market by Type (Mollusk, Sponge, Tunicate, Fish, Others), By Application (Antitumor Drugs, Anti-Cardiovascul) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131925 3300 Pharma & Healthcare 377 233 Pages 5 (42)
                                          

Market Overview:


The global marine derived drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for marine-derived drugs for the treatment of various diseases, such as cancer and cardiovascular diseases. In addition, the growing awareness about the benefits of marine-derived drugs is also contributing to the growth of this market. The global marine derived drugs market can be segmented on the basis of type, application, and region. On the basis of type, this market can be divided into mollusk, sponge, tunicate fish and others segments. The mollusk segment is expected to account for a major share in terms revenue in 2018 owing to its wide range applications in drug discovery and development processes across different therapeutic areas such as oncology and cardiology among others. By application, antitumor drugs are anticipated witness highest growth rate over next few years due high prevalence cancer cases coupled with increasing R&D investments by key players operating in this space across globe .


Global Marine Derived Drugs Industry Outlook


Product Definition:


A Marine Derived Drug is a term used to describe a drug that has been isolated from marine life. Marine derived drugs are important because they can be used to treat diseases that have been resistant to traditional treatments.


Mollusk:


Mollusks are gastropods that live in the sea and have a soft body. The most commonly used mollusk for drug development is the abalone which has been used to develop antibiotics, anti-inflammatory drugs, blood pressure drugs and vaccines among others.


Sponge:


Sponge is a porous, hollow fiber that has been used as an absorbent for marine organisms. Marine sponges are used in the production of biopharmaceuticals such as vaccines and monoclonal antibodies owing to their ability to produce high levels of proteins. Sponge extracts have been reported to contain immunosuppressive and anti-inflammatory compounds which may be useful in the development of drugs targeting autoimmune diseases, inflammatory processes or cancer.


Application Insights:


The market is segmented based on application into antitumor drugs, anti-cardiovascular drugs, antibiotics, antidiabetic drugs and others. In 2017, the anti-cancer segment dominated the global marine derived drug market owing to increasing cancer cases across the globe. The rising number of cancer cases has led to a growing demand for marine derived anticancer drugs which are effective against resistant tumor cells.


Antitumor Drugs held a significant share in 2017 due to high incidence of various types of cancers such as lung cancer and breast carcinoma among women which have become difficult for conventional treatment methods to treat due to resistance developed by tumor cells. This trend is expected continue over the forecast period with introduction of new products with enhanced efficacy coupled with fewer side effects than conventional therapies that will further boost industry growth during future years.


Regional Analysis:


Asia Pacific dominated the global marine derived drugs market in 2017. The presence of a large number of manufacturers and suppliers coupled with increasing R&D activities in this region is expected to drive the market growth over the forecast period. In addition, high consumption of seafood is also driving demand for these products in this region. Increasing disposable income levels and growing consumer awareness regarding advanced therapies are some factors contributing to regional growth.


The Asia Pacific therapeutics sector has witnessed significant investment from various governments as well as private players over the past few years owing to its potential for rapid economic development along with an abundant supply of raw materials.


Growth Factors:


  • Increasing demand for marine derived drugs for the treatment of various diseases such as cancer, arthritis, and Alzheimer's disease.
  • Growing research and development activities in the field of marine derived drugs to develop novel therapeutics.
  • Rising number of collaborations between pharmaceutical companies and research institutes to develop new marine-based drugs.
  • increasing investment by government agencies in Marine Derived Drugs market research to find new sources for drug discovery

Scope Of The Report

Report Attributes

Report Details

Report Title

Marine Derived Drugs Market Research Report

By Type

Mollusk, Sponge, Tunicate, Fish, Others

By Application

Antitumor Drugs, Anti-Cardiovascul

By Companies

Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, Johnson and Johnson, GSK, TerSera Therapeutics, Teva

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Marine Derived Drugs Market Report Segments:

The global Marine Derived Drugs market is segmented on the basis of:

Types

Mollusk, Sponge, Tunicate, Fish, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Antitumor Drugs, Anti-Cardiovascul

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Seattle Genetics
  2. Eisai Co
  3. Tekada
  4. Pfizer
  5. Pharma Mar
  6. Johnson and Johnson
  7. GSK
  8. TerSera Therapeutics
  9. Teva

Global Marine Derived Drugs Market Overview


Highlights of The Marine Derived Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Mollusk
    2. Sponge
    3. Tunicate
    4. Fish
    5. Others
  1. By Application:

    1. Antitumor Drugs
    2. Anti-Cardiovascul
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Marine Derived Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Marine Derived Drugs Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Marine Derived Drugs Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Marine Derived Drugs Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Marine Derived Drugs Market - Supply Chain
   4.5. Global Marine Derived Drugs Market Forecast
      4.5.1. Marine Derived Drugs Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Marine Derived Drugs Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Marine Derived Drugs Market Absolute $ Opportunity

5. Global Marine Derived Drugs Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Marine Derived Drugs Market Size and Volume Forecast by Type
      5.3.1. Mollusk
      5.3.2. Sponge
      5.3.3. Tunicate
      5.3.4. Fish
      5.3.5. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Marine Derived Drugs Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Marine Derived Drugs Market Size and Volume Forecast by Application
      6.3.1. Antitumor Drugs
      6.3.2. Anti-Cardiovascul
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Marine Derived Drugs Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Marine Derived Drugs Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Marine Derived Drugs Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Marine Derived Drugs Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Marine Derived Drugs Demand Share Forecast, 2019-2029

9. North America Marine Derived Drugs Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Marine Derived Drugs Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Marine Derived Drugs Market Size and Volume Forecast by Application
      9.4.1. Antitumor Drugs
      9.4.2. Anti-Cardiovascul
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Marine Derived Drugs Market Size and Volume Forecast by Type
      9.7.1. Mollusk
      9.7.2. Sponge
      9.7.3. Tunicate
      9.7.4. Fish
      9.7.5. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Marine Derived Drugs Demand Share Forecast, 2019-2029

10. Latin America Marine Derived Drugs Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Marine Derived Drugs Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Marine Derived Drugs Market Size and Volume Forecast by Application
      10.4.1. Antitumor Drugs
      10.4.2. Anti-Cardiovascul
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Marine Derived Drugs Market Size and Volume Forecast by Type
      10.7.1. Mollusk
      10.7.2. Sponge
      10.7.3. Tunicate
      10.7.4. Fish
      10.7.5. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Marine Derived Drugs Demand Share Forecast, 2019-2029

11. Europe Marine Derived Drugs Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Marine Derived Drugs Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Marine Derived Drugs Market Size and Volume Forecast by Application
      11.4.1. Antitumor Drugs
      11.4.2. Anti-Cardiovascul
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Marine Derived Drugs Market Size and Volume Forecast by Type
      11.7.1. Mollusk
      11.7.2. Sponge
      11.7.3. Tunicate
      11.7.4. Fish
      11.7.5. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Marine Derived Drugs Demand Share, 2019-2029

12. Asia Pacific Marine Derived Drugs Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Marine Derived Drugs Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Marine Derived Drugs Market Size and Volume Forecast by Application
      12.4.1. Antitumor Drugs
      12.4.2. Anti-Cardiovascul
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Marine Derived Drugs Market Size and Volume Forecast by Type
      12.7.1. Mollusk
      12.7.2. Sponge
      12.7.3. Tunicate
      12.7.4. Fish
      12.7.5. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Marine Derived Drugs Demand Share, 2019-2029

13. Middle East & Africa Marine Derived Drugs Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Marine Derived Drugs Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Marine Derived Drugs Market Size and Volume Forecast by Application
      13.4.1. Antitumor Drugs
      13.4.2. Anti-Cardiovascul
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Marine Derived Drugs Market Size and Volume Forecast by Type
      13.7.1. Mollusk
      13.7.2. Sponge
      13.7.3. Tunicate
      13.7.4. Fish
      13.7.5. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Marine Derived Drugs Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Marine Derived Drugs Market: Market Share Analysis
   14.2. Marine Derived Drugs Distributors and Customers
   14.3. Marine Derived Drugs Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Seattle Genetics
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Eisai Co
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Tekada
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Pfizer
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Pharma Mar
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Johnson and Johnson
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. GSK
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. TerSera Therapeutics
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Teva
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us